View the latest RELIEF THERAPEUTICS Holding AG (RLFTF) stock price, news, historical charts, analyst ratings and financial information from WSJ. Subscriber Agreement & Terms of Use, Relief Therapeutics employs 10 workers across the globe. Is it profitable to invest in Relief Therapeutics Holding AG stock? But what fascinates me most, is two fold. Subscribe to Premium to view Fair Value for RLFTF. Relief Therapeutics Holding AG (RLFTF) stock price prediction is 1.093074 USD. Log in to see them here or sign up to get started. Relief Increases Issued Share Capital with Creation of Treasury Shares. One share of RLFTF stock can currently be purchased for approximately $0.32. RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today, Traders Have Rotated Into Big Multinational Companies On OTC Markets. RLFTF Relief Therapeutics Holding AG — Stock Price and Discussion | Stocktwits. Copyright © 2021 MarketWatch, Inc. All rights reserved. Get the latest RELIEF THERAPEUTICS Holding SA (RLFTF) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Relief Therapeutics (RLFTF) ... Today’s market activity was an over-reaction (just like when this tanked to 29c in Dec). For the best MarketWatch.com experience, please update to a modern browser. RLFTF remains one of our favorite COVID-19 plays here at Insider Financial. Your losses are our losses too. The first is the science and open label study results. Organigram shares gain as British American Tobacco buys 19.9% stake, to cooperate on CBD products, What to do if you already filed taxes but want to claim the $10,200 unemployment tax break, Airline Stocks: 2 Big Reasons AAL, DAL and UAL Stock Are Soaring Today. Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. It engages in the development and licensing of its portfolio of medicinal products candidates. RLFTF Charts (Price in USD) - 2021-01-22 Stock Forecast / Price Prediction / Prognosis: Relief Therapeutics Holding AG Forecast Predictions, Comments & Questions RLFTF:OTC US Stock Quote - Relief Therapeutics Holding AG - Bloomberg Markets. RLFTF closed up 14.66 percent on Tuesday, February 23, 2021, on 3.76 times normal volume. The RLFTF stock price can go up from 0.329 USD to 0.733 USD in one year. Find the latest RELIEF THERAPEUTICS HOLDING AG (RLFTF) stock quote, history, news and other vital information to help you with your stock trading and investing. View real-time stock prices and stock quotes for a full financial overview. Latest stock price today and the US's most active stock market forums. Visit a quote page and your recently viewed tickers will be displayed here. michaelquale Nov 12, 2020. Uber Is Seeing an Improvement in Rides. GENEVA, SWITZERLAND / ACCESSWIRE / February 24, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100(TM) (aviptadil) in advanced clinical development, announces that NeuroRx, Inc. has reported data from the Phase 2b/3 trial of RLF-100(TM) for the treatment of Respiratory Failure in Critical COVID-19 patients. NeuroRx a company who is partnered with promising COVID-19 therapeutic maker Relief Therapeutics (OTC: RLFTF) has decided to merge and list with a NYSE company (3-6 months).. Get RELIEF THERAPEUTICS Holding SA (RLFTF:OTCQB) real-time stock quotes, news, price and financial information from CNBC. Why Its Stock Could Still Be a Buy. Free forex prices… (QB) (RLFTF) stock price, charts, trades & the US's most popular discussion forums. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Add RLFTF Price Alert Hide Sticky Hide Intro Moderator: PennyWorld , Millstone , TraderInvictus , Andy2018 , Tiger Money , roofus krile Search This Board: 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003+ In our last profile of the company, we focused on the science and background of RLF-100™, also known as Aviptadil. Trending now. According to the interview with Dr. Javitt the term sheet has already been signed, big banks are already doing their due diligence and vetting and expressed interest in bookrunning. What Will the Stock Market Do Today? In this article, we are going to take a look at the latest developments and how we think the rest of 2020 is going to play out for RLFTF and its shareholders. Find the latest RELIEF THERAPEUTICS HOLDING AG (RLFTF) stock quote, history, news and other vital information to help you with your stock trading and investing. 9. ... Price to Sales Ratio: N/A: ... Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. 3,886.83. Its products include aviptadil, for respiratory indications such as sarcoidosis and pulmonary hypertension; and atexakin alfa, for the treatment of diabetic neuropathy. GENEVA, SWITZERLAND / ACCESSWIRE / March 8, 2021 / RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced that its Board of Directors approved an increase of the Company's registered share capital from 3,246,727,248 to 3,371,727,248 shares through the issuance of 125,000,000 shares at an issue price of CHF 0. All quotes are in local exchange time. Close price at the end of the last trading day (Friday, 30th Oct 2020) of the RLFTF stock was $0.53. A high-level overview of Relief Therapeutics Holding AG (RLFTF) stock. Predictions of RLFTF stock price for tomorrow. There are currently no items in this Watchlist. Check out our RLFTF stock analysis, current RLFTF quote, charts, and historical prices for Mondobiotech Holding Ag Basel stock Find market predictions, RLF financials and market news. © 2021 Verizon Media. All rights reserved. RLFTF Profile. RELIEF THERAPEUTICS Holding AG is a clinical stage biotechnology company. GENEVA, SWITZERLAND / ACCESSWIRE / March 12, 2021 / RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced that it has entered into a definitive agreement with a single healthcare-dedicated U. institutional investor to purchase in a private placement 41,459,370 of Relief common stock at a purchase price of CHF 0. GENEVA, SWITZERLAND / ACCESSWIRE / March 8, 2021 / RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today … RLFTF: Get the latest Relief Therapeutics stock price and detailed information including RLFTF news, historical charts and realtime prices. 4 Big Stories to Watch. The 125,000,000 new shares, to be issued out of the Company's authorized capital, are fully subscribed for by Relief Therapeutics International SA, its 100% wholly owned subsidiary, and will be listed on the SIX Swiss Exchange on or around March 11, 2021. 31,148.24. NASDAQ. During the day the stock fluctuated 3.71% from a day low at $0.53 to a day high of $0.54. Relief Therapeutics Holding AG, a clinical stage biotechnology company, engages in developing treatment solutions for indications related to diabetic complications and respiratory diseases. FTSE 100. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.